Genentech, Inc. (DNA) Lobbying Data
DNA lobbying summary
Genentech (DNA) has reported $98.3M in federal lobbying spending across 447 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent. Lobbying firms used include Genentech, Inc, Tarplin, Downs & Young, LLC, Todd Strategy Group.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $11.1M |
| 2025 | $13.4M |
| 2024 | $12.1M |
| 2023 | $12.5M |
| 2022 | $11.8M |
| 2021 | $15.2M |
See insider trading for DNA or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.